JAMA Otolaryngology–Head & Neck Surgery : Pathologic Treatment Effect and Survival in HPV-Negative HNSCC Following Neoadjuvant Nivolumab
JAMA Network
00:00
Examining Patient Outcomes in HPV-Negative HNSCC Treatment
This chapter outlines the criteria and characteristics of patients participating in a study on immunotherapy for HPV-negative head and neck squamous cell carcinoma. It emphasizes response rates to treatment and examines the correlation between early pathological responses and long-term survival outcomes.
Transcript
Play full episode
